Advanced search
Publication Cover
Current Medical Research and Opinion Volume 38, 2022 - Issue 11
Submit an article Journal homepage
337
Views
4
CrossRef citations to date
0
Altmetric
Cardiovascular Medicine

Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19

Steven Deitelzweiga Department of Hospital Medicine, Ochsner Clinic Foundation, New Orleans, LA, USA;b Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, USACorrespondence[email protected]
,
Julia Zhuc Bristol Myers Squibb, Lawrenceville, NJ, USA
,
Jenny Jiangc Bristol Myers Squibb, Lawrenceville, NJ, USA
,
Xuemei Luod Pfizer, New York, NY, USA
,
Allison Keshishiane STATinMED LLC, Dallas, TX, USA
,
Mauricio Ferric Bristol Myers Squibb, Lawrenceville, NJ, USA
,
Lisa Rosenblattc Bristol Myers Squibb, Lawrenceville, NJ, USA
,
Patricia Schulerc Bristol Myers Squibb, Lawrenceville, NJ, USA
,
Cynthia Gutierreze STATinMED LLC, Dallas, TX, USA
&
Amol D. Dhamanec Bristol Myers Squibb, Lawrenceville, NJ, USA
 show all
Pages 1891-1896 | Received 08 Jun 2022, Accepted 10 Aug 2022, Published online: 30 Aug 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Adane Teshome Kefale, Woldesellassie M. Bezabhe & Gregory M. Peterson. (2023) Clinical outcomes of oral anticoagulant discontinuation in atrial fibrillation: a systematic review and meta-analysis. Expert Review of Clinical Pharmacology 16:7, pages 677-684.
Read now
Juan José Cerezo Manchado, Teodoro Iturbe Hernández, María del Carmen Martínez Pacheco, Ignacio Gil Ortega, Desirée Campoy, Tania Canals Pernas, Laia Martínez Serra, Katia Jessica Flores Aparco, César Andrés Velásquez Escandón, Antonio Martínez Francés & Pável Olivera. (2023) Impact of atrial fibrillation and anticoagulation on the risk of death, thromboembolic disease and bleeding in patients with COVID-19: the ACO-VID Registry. Current Medical Research and Opinion 39:6, pages 811-817.
Read now

Articles from other publishers (2)

Sohair M. Aboelghar, Maha A. Hegazy & Hebatallah A. Wagdy. (2024) Ecofriendly bioanalytical validated RP-HPLC method for simultaneous determination of COVID-19 co-prescribed drugs employing quality by design and green chemistry. Microchemical Journal 200, pages 110292.
Crossref
Amitabha Ray, Kristen A. K. Winter, Dayalu S. L. Naik & Chuku Okorie. (2023) Prognostic Significance of the Coagulation and Complement Systems in Critical COVID-19 Infection. Prague Medical Report 124:2, pages 77-93.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.